MARKET

COCP

COCP

Cocrystal Pharma Inc
NASDAQ
1.170
+0.020
+1.74%
After Hours: 1.170 0 0.00% 17:26 09/25 EDT
OPEN
1.180
PREV CLOSE
1.150
HIGH
1.180
LOW
1.142
VOLUME
13.38K
TURNOVER
--
52 WEEK HIGH
2.030
52 WEEK LOW
0.7600
MARKET CAP
22.54M
P/E (TTM)
-1.5429
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at COCP last week (0914-0918)?
Weekly Report · 6d ago
Weekly Report: what happened at COCP last week (0907-0911)?
Weekly Report · 09/14 09:26
Cocrystal Pharma Announces Last Subject Dosed In Phase 1b Norovirus Study
NASDAQ · 09/09 13:53
Cocrystal Pharma Completes Dosing in Norovirus Phase 1b Study
TipRanks · 09/09 12:41
Cocrystal Pharma doses last subject in norovirus challenge study
TipRanks · 09/09 11:26
Weekly Report: what happened at COCP last week (0831-0904)?
Weekly Report · 09/07 09:24
Weekly Report: what happened at COCP last week (0824-0828)?
Weekly Report · 08/31 09:26
Weekly Report: what happened at COCP last week (0817-0821)?
Weekly Report · 08/24 09:27
More
About COCP
Cocrystal Pharma, Inc. is a clinical-stage biotechnology company. The Company is engaged in discovering and developing novel antiviral therapeutics that target the replication process of influenza viruses, coronaviruses (including SARS-CoV-2), noroviruses and hepatitis C viruses (HCV). It is developing small molecule antiviral therapeutics that inhibit the essential viral replication function of RNA viruses, causing acute and chronic viral diseases. It has several candidates under development for the treatment of influenza infection. CC-42344 is a novel PB2 inhibitor, which is a preclinical lead for the treatment of pandemic and seasonal influenza A. It also develops broad-spectrum influenza antivirals targeting replication enzymes of influenza A and B strains. Its broad-spectrum antiviral drug candidate, CDI-988, is an oral treatment for SARS-CoV-2, the virus that causes COVID-19. Its CC-31244, an HCV NNI, is a pan-genotypic inhibitor of NS5B polymerase for the treatment of HCV.

Webull offers Cocrystal Pharma Inc stock information, including NASDAQ: COCP real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, COCP stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading COCP stock methods without spending real money on the virtual paper trading platform.